<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CBAY
Acquired by GILD
$
()


  • Gilead completes acquisition of CymaBay

    3/22/2024 - 09:27am
  • Gilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45

    3/22/2024 - 09:27am
  • CymaBay announces European Medicine accepts for review the MAA for seladelpar

    3/4/2024 - 08:10am
  • Savara price target raised by $9 at Piper Sandler, here's why

    3/4/2024 - 07:31am
  • CymaBay reports Q4 EPS (35c), consensus (31c)

    2/28/2024 - 17:13pm
  • CymaBay's seladelpar shows efficacy in Phase 3 study featured in NEJM

    2/21/2024 - 17:49pm
  • CymaBay just downgraded at Leerink, here's why

    2/19/2024 - 20:14pm
  • Biotech Alert: Searches spiking for these stocks today

    2/15/2024 - 11:05am
  • Biotech Alert: Searches spiking for these stocks today

    2/14/2024 - 11:08am
  • CymaBay just downgraded at LifeSci Capital, here's why

    2/14/2024 - 04:59am
  • CymaBay just downgraded at UBS, here's why

    2/14/2024 - 04:44am
  • CymaBay just downgraded at Piper Sandler, here's why

    2/13/2024 - 16:06pm
  • CymaBay just downgraded at BTIG, here's why

    2/13/2024 - 07:11am
  • CymaBay just downgraded at H.C. Wainwright, here's why

    2/13/2024 - 06:08am
  • CymaBay just downgraded at Raymond James, here's why

    2/12/2024 - 18:04pm
dynamic_feed Breaking News